Objective To investigate the role and action mechanism of chemokine (C- X- C motif) receptor 3 (CXCR3) in hepatic ischemia- reperfusion injury (IRI) .Methods Forty- eight mice were divided into operation group and sham- operation group.The operation group was treated to establish a mouse model of IRI.Liver tissues were obtained at 3, 6, 12, and 24 h after IRI, with 6 mice at each time point.The expression of chemokine (C- X- C motif) ligand 9- 11 (CXCL9- 11) and their receptor CXCR3 were measured by real- time PCR and Western blot.The effect of CXCR3 was blocked by its specific antagonist C6.Hepatic injury was estimated based on the activity of hepatic transaminase and morphological indices.The distribution of subsets of infiltrating T cells was analyzed by flow cytometry.All data were expressed as mean ± standard deviation.Comparison between groups was made by one- way analysis of variance.Results Compared with the sham- operation group, the operation group had significantly upregulated expression of CXCL9- 11 and CXCR3 at all time points after IRI (P < 0.05) .Blocking CXCR3 significantly protected liver function and morphology (P < 0.05) .Antagonist C6 significantly reduced Th1 cell infiltration (P < 0.01) , but significantly increased Treg infiltration (P < 0.01) .Conclusion CXCR3 is an ideal therapeutic target in IRI treatment due to its relationship with immunoregulation.
[1]BAHDE R, SPIEGEL HU.Hepatic ischaemia-reperfusion injury from bench to bedside[J].Br J Surg, 2010, 97 (10) :1461-1475.
|
[2]PRANZATELLI MR, TATE ED, McGEE NR, et al.Expression of CXCR3 and its ligands CXCL9, -10 and-11 in paediatric opsoclonus-myoclonus syndrome[J].Clin Exp Immunol, 2013, 172 (3) :427-436.
|
[3]WEIGT SS, DERHOVANESSIAN A, LIAO E, et al.CXCR3 chemokine ligands during respiratory viral infections predict lung allograft dysfunction[J].Am J Transplant, 2012, 12 (2) :477-484.
|
[4]HOSSAIN MA, WAKABAYASHI H, IZUISHI K, et al.The role of prostaglandins in liver ischemia-reperfusion injury[J].Curr Pharm Des, 2006, 12 (23) :2935-2951.
|
[5]PARK JW, LI Z, CHOI JS, et al.Expression of CXCL9, -10, and-11 in the aqueous humor of patients with herpetic endotheliitis[J].Cornea, 2012, 31 (11) :1246-1250.
|
[6]MANOUSOU P, KOLIOS G, DRYGIANNAKIS I, et al.CXCR3axis in patients with primary biliary cirrhosis:a possible novel mechanism of the effect of ursodeoxycholic acid[J].Clin Exp Immunol, 2013, 172 (1) :9-15.
|
[7]SAHIN H, BORKHAM-KAMPHORST E, KUPPE C, et al.Chemokine Cxcl9 attenuates liver fibrosis-associated angiogenesis in mice[J].Hepatology, 2012, 55 (5) :1610-1619.
|
[8]SHEN J, GAO J, CHEN C, et al.Antifibrotic role of chemokine CXCL9 in experimental chronic pancreatitis induced by trinitrobenzene sulfonic acid in rats[J].Cytokine, 2013, 64 (1) :382-394.
|
[9]MOCHIZUKI M, SUGITA S, KAMOI K.Immunological homeostasis of the eye[J].Prog Retin Eye Res, 2013, 33:10-27.
|
[10]NOBREGA C, NUNES-ALVES C, CERQUEIRA-RODRIGUES B, et al.T cells home to the thymus and control infection[J].J Immunol, 2013, 190 (4) :1646-1658.
|
[11]CHAOUAT G.Inflammation, NK cells and implantation:friend and foe (the good, the bad and the ugly?) :replacing placental viviparity in an evolutionary perspective[J].J Reprod Immunol, 2013, 97 (1) :2-13.
|
[12]OH H, GHOSH S.NF-kappaB:roles and regulation in different CD4 (+) T-cell subsets[J].Immunol Rev, 2013, 252 (1) :41-51.
|
[13]TAFLIN C, CHARRON D, GLOTZ D, et al.Regulation of the CD4+T cell all-immune response by endothelial cells[J].Hum Immunol, 2012, 73 (12) :1269-1274.
|